Human cytochromes P450 1A1 and 1A2 participate in detoxication of carcinogenic aristolochic acid

Neuroendocrinology Letters

Volumn 29, Issue 5, 2008, Pages 733-737

  Šístková, Jana ^a   Hudeček, Jiří ^a   Hodek, Petr ^a   Frei, Eva ^b   Schmeiser, Heinz H ^b   Stiborová, Marie ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Aristolochic acid; Aristolochic acid nephropathy; Balkan endemic nephropathy; Carcinogen; Detoxication; HPLC

Indexed keywords

ARISTOLOCHIC ACID; ARISTOLOCHIC ACID 1; ARISTOLOCHIC ACID 1A; CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DETOXIFICATION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ISOLATION; ENZYME METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER MICROSOME METABOLISM; MALE; MOUSE; NONHUMAN; RAT; SEPARATION TECHNIQUE;

EID: 57149122064     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Arlt VM, Alunni-Perret M, Quatrehomme G, Ohayon P, Albano L, Gaid H, Michiels JF, Meyrier A, Cassuto E, Wiessler M, Schmeiser HH, Cosyns J-P. Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer. Int J Cancer 2004; 111: 977-980.
2. Arlt VM, Ferluga D, Stiborova M, Pfohl-Leszkowicz A, Vukelic M, Vdovic S, Schmeiser HH, Cosyns JP. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer 2002; 101: 500-502.
3. Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002; 17: 265-277.
4. Cosyns JP. Aristolochic acid and "Chinese herbs nephropathy": a review of the evidence to date. Drug Safety 2003; 26: 33-48.
5. Dračínská H, Mikšanová M, Svobodová M, Smrček S, Frei E, Schmeiser HH, Stiborová M. Oxidative detoxication of carcinogenic 2-nitroanisole by human, rat and rabbit cytochrome P450. Neuroendocrinol Lett 2006; 27(Suppl. 2): 9-13.
6. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky R, Goodenough AK, Rieger R, Vukelic M, Jelakovic B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy, Proc Natl Acad Sci USA 2007; 104: 12129-12134.
7. Hranjec T, Kovac A, Kos J, Mao W, Chen JJ, Grollman AP, Jelakovic B. Endemic nephropathy: the case for chronic poisoning by aristolochia. Croat Med J 2005; 46: 116-125.
8. IARC. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monographs Evaluating Carcinogenic Risks for Human, Vol. 82, 2002.
9. Ivic M. Etiology of endemic nephropathy. Lijec Vjesn 1969; 91: 1273-1281.
10. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl J Med 2000; 342: 1686-1692.
11. Reynisson J, Stiborová M, Martínek V, Gamboa da Costa G, Phillips DH, Arlt VM. Mutagenic potential of nitrenium ions of nitrobenzanthrones: correlation between theory and experiment. Environm Mol Mutagenesis 2008; 49: 659-667.
12. Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 1996; 56: 2025-2028.
13. Stefanovic V, Toncheva D, Atanasova S, Polenakovic M. Etiology of Balkan endemic nephropathy and associated urothelial cancer. Am J Nephrol 2006; 26: 1-11.
14. Stiborová M, Frei E, Arlt VM, Schmeiser H.H. Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy. Mutat Res 2008; 658: 55-67.
15. Stiborová M, Frei E, Schmeiser HH. Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid. Kidney Int 2008; 73: 1209-1211.
16. 32P-postlabeling analysis of DNA adduct formation. Mutat Res 2001; 493: 149-160.
17. Stiborová M, Frei E, Wiessler M, Schmeiser HH. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochrome P450 1A1 and 1A2. Chem Res Toxicol 2001; 14: 1128-1137.
18. Stiborová M, Hudeček J, Frei E, Schmeiser HH. Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers. Interdisc Toxicol 2008; 1: 8-12.
19. 5. Neuroendocrinol Lett 2006; 27(Suppl. 2): 35-39.
20. Stiborová M, Patočka J, Frei E, Schmeiser HH. Biochemistry and toxicological aspects of etiology of Balkan endemic nephropathy [in Czech]. Chem Listy 2005; 99: 782-788.
21. Stiborová M, Sopko B, Hodek P, Frei E, Schmeiser HH, Hudeček J. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen. Cancer Lett 2005; 229: 193-204.
22. Tatu CA, Oren WH, Finkelman RB, Feder GL. The etiology of Balkan endemic nephropathy: still mote questions than answers. Environ Health Perspect 1998; 106: 689-700.
23. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Valdervelde D, Verbeelen D, Vanhaelen-Fastre B, Vanhaelen M. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387-391.
24. Xiao Y, Ge M, Xue X, Wang H, Wu X, Li L, Liu L, Qi X, Zhang Y, Li Y, Xie T, Gu J, Ren J. Detoxication role of hepatic cytochrome P450s in the kidney toxicity induced by aristolochic acid. Kidney Int 2008; 73: 1231-1239.